{"schema_version":"secwatch.filing_event.v1","accession":"0000886206-22-000011","form_type":"8-K","ticker":"FC","cik":"0000886206","company_name":"FRANKLIN COVEY CO","filed_at":"2022-03-30T23:59:59+00:00","discovered_at":"2026-05-14T18:04:10.173239+00:00","generated_at":"2026-06-26T14:10:35.540959+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Franklin Covey Q2 sales +18% to $56.6M; Adj EBITDA +57% to $8.0M; FY22 guidance raised","bullets":["Sales $56.6M (+18% YoY); AAP subscription sales $32M (+29%); Education revenue +31%.","Operating income $3.5M vs $0.8M; net income $1.9M ($0.13 diluted EPS) vs net loss in prior year.","Adj EBITDA $8.0M (+57%); rolling four-quarter Adj EBITDA $37.1M (+163% vs prior year period).","Billed+unbilled deferred revenue $119.3M (+24%); cash $61.1M; total liquidity $76M.","FY2022 guidance raised: Adj EBITDA expected $38M-$39M, representing ~37.5% growth vs FY2021."],"urls":{"canonical":"https://secwatch.observer/filing/0000886206-22-000011","json":"https://secwatch.observer/filing/0000886206-22-000011.json","markdown":"https://secwatch.observer/filing/0000886206-22-000011.md","text":"https://secwatch.observer/filing/0000886206-22-000011.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/886206/000088620622000011/0000886206-22-000011-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/886206/000088620622000011/fc-20220330x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T14:10:35.540959+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}